Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

23 results
Display

Prevalent factor XII deficiency in cancer patients with isolated aPTT prolongation

Shin DY, Lee HR, Kang HJ, Na II, Chang YH, Yang SH

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Epstein-Barr Virus-positive Diffuse, Large B-cell Lymphoma after Angioimmunoblastic T-cell Lymphoma

Choi YH, Kim HS, Nam SB, Kang HJ, Na II, Yang SH, Ryoo BY

Angioimmunoblastic T-cell lymphoma (AITL) is a systemic lymphoproliferative disorder that presents with profound immune dysfunction and immunodeficiency. As in many other immunodeficiencies, Epstein-Barr virus (EBV) associated B-cell lymphoid proliferation can...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase II Trial of Vinorelbine and Cisplatin Chemotherapy in Advanced Non-Small Cell Lung Cancer

Joh YH, Kim TY, Na II, Oh DY, Kim BS, Kim JH, Kim DY, Lee SH, Yoo CG, Lee CT, Kim YW, Heo DS, Bang YJ, Han SK, Shim YS, Kim NK

  • KMID: 1804426
  • Cancer Res Treat.
  • 2001 Oct;33(5):373-376.
PURPOSE: Platinum-based chemotherapy has conferred a modest but significant survival benefit and the introduction of newer drugs has led to achieve higher response rate in patients with advanced non-small cell...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Durable Response to Pazopanib in a Patient with Metastatic Alveolar Soft Part Sarcoma

Han J, Na II, Jung MW, Lee SH, An JW, Koh JS

Alveolar soft part sarcoma (ASPS) is a rare form of soft tissue sarcoma, and frequently, metastases are found at diagnosis. In patients with metastatic or unresected ASPS, systemic treatment is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Graft-Versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation with Non-Myeloablative Conditioning: Experiences at a Single Center

Na II, Shin H, Song EK, Lee KW, Yun T, Kim JH, Yoon SS, Lee JS, Park S, Kim BK

BACKGROUND: The use of non-myeloablative stem cell transplantation (NST) has recently been increasing for treating the patients who cannot tolerate ablative hematopoietic stem cell transplantation (HSCT). Although graft-versus-host disease (GVHD)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Gefitinib-Related Interstitial Pneumonia

Lee HJ, Nam SB, Jung JW, Na II, Kim CH, Ryoo BY, Choe DW, Kang JH, Lee JC

Gefitinib is a novel drug used to treat advanced non-small cell lung cancer. However, drug-related interstitial pneumonia is a major life-threatening side effect, which has a worldwide prevalence of 0.3-0.4%....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Decision Tree Model for Predicting Hospice Palliative Care Use in Terminal Cancer Patients

Purpose: This study attempted to develop clinical guidelines to help patients use hospice and palliative care (HPC) at an appropriate time after writing physician orders for lifesustaining treatment (POLST) by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prostatic Cancer Presenting as an Isolated Large Lung Mass

No HS, Lee JH, Ahn Y, Na II, Kim HR, Kim CH, Koh JS, Lee JC

  • KMID: 2319319
  • Tuberc Respir Dis.
  • 2010 May;68(5):290-293.
A hidden primary tumor presenting as an isolated lung mass is a diagnostic challenge to physicians because the diagnosis of lung cancer is likely to be made if the histologic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Phase II Study of Low-dose Paclitaxel and Cisplatin as a Second-line Therapy after 5-Fluorouracil/Platinum Chemotherapy in Gastric Cancer

Lee KW, Kim JH, Yun T, Song EK, Na II, Shin H, Oh SY, Choi IS, Oh DY, Kim DW, Im SA, Kim TY, Lee JS, Heo DS, Bang YJ, Kim NK

This study was performed to evaluate the efficacy and toxicity of low-dose paclitaxel/cisplatin chemotherapy in patients with metastatic or recurrent gastric cancer that had failed 5-fluorouracil/platinum-based chemotherapy. Thirty-two patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

Lee DW, Im SA, Kim YJ, Yang Y, Rhee J, Na II, Lee KH, Kim TY, Han SW, Choi IS, Oh DY, Kim JH, Kim TY, Bang YJ

PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic factors of breast cancer in Koreans

Kim HK, Bang SM, Byun JH, Ryu MH, Lee WS, Lee KS, Jeong JY, Kim JH, Lee SH, Na II, Heo DS, Bang YJ, Kim NK

  • KMID: 2251319
  • Korean J Med.
  • 2000 Apr;58(4):446-452.
BACKGROUND: The aim of this study is to determine prognostic factors of breast cancer in Korean patients who underwent curative mastectomy. METHODS: Medical records of 181 patients who underwent curative mastectomy were...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Four Cases of Hematologic Malignancy Following Radioactive Iodine Therapy for Thyroid Cancer

Im M, Lee JK, Hong YJ, Hong SI, Kang HJ, Na II, Ryoo BY, Cheon GJ, Lee HN, Chang YH

Ionizing radiation including I131 might produce chromosomal translocation, causing hematologic malignancy. The incidence of leukemia following radioactive iodine treatment for thyroid cancer has been reported to be approximately 0.1 to...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Medullary Thyroid Carcinoma with Ectopic Adrenocorticotropic Hormone Syndrome

Choi HS, Kim MJ, Moon CH, Yoon JH, Ku HR, Kang GW, Na II, Lee SS, Lee BC, Park YJ, Kim HI, Ku YH

Ectopic adrenocorticotropic hormone (ACTH) syndrome is caused most frequently by a bronchial carcinoid tumor or by small cell lung cancer. Medullary thyroid carcinoma (MTC) is a rare etiology of ectopic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Acute myelogenous leukemia in the elderly (>or=60): retrospective study of 115 patients

Shin HC, Na II, Yun T, Lee KW, Song EG, Choi IS, Oh DY, Kim JH, Lee JS, Yoon SS, Park S, Kim BK, Kim NK

  • KMID: 2081194
  • Korean J Med.
  • 2006 Feb;70(2):196-206.
BACKGROUND: Acute myelogenous leukemia (AML) is frequently encountered in elderly patients whereas intensive chemotherapy yield lower rate of complete remission (CR) and survival than young patients. This study was aimed...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical Features Reflect Exon Sites of EGFR Mutations in Patients with Resected Non-Small-Cell Lung Cancer

Na II, Rho JK, Choi YJ, Kim CH, Koh JS, Ryoo BY, Yang SH, Lee JC

The aim of the current study was to determine the clinical significance according to the subtypes of epidermal growth factor receptor (EGFR) mutations and presence of KRAS mutations in operable...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factors of Gastrointestinal Leiomyosarcoma in Korea

Lee SH, Cha HJ, Kim JH, Na II, Lee JH, Kim HK, Lee KS, Lee WS, Kim CJ, Heo DS, Bang YJ, Kim NK

  • KMID: 2329187
  • J Korean Cancer Assoc.
  • 2000 Dec;32(6):1022-1030.
PURPOSE: The clinicopathologic features and prognostic factors of gastrointestinal leiomyosarcoma have been a source of controversy. MATERIALS AND METHODS: A retrospective study was made of 91 incident cases of gastrointestinal leiomyosarcoma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Evaluation of Adrenal Masses in Lung Cancer Patients Using F-18 FDG PET/CT

Cho AR, Lim I, Na II, Choe DH, Park JY, Kim BI, Cheon GJ, Choi CW, Lim SM

  • KMID: 2051994
  • Nucl Med Mol Imaging.
  • 2011 Mar;45(1):52-58.
PURPOSE: The aim of this study was to assess the diagnostic efficacy of PET/CT using various parameters for the characterization of adrenal nodules in lung cancer patients. METHODS: Sixty-one adrenal nodules...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Factor Analysis of Aggressive Non - Hodgkin's Lymphoma Based on International Prognostic Index Model

Ryu MH, Park YI, Kim HK, Lee DH, Jeong JY, Kim DW, Na II, Kim JH, Lee SH, Heo DS, Bang YJ, Park SY, Kim BK, Kim NK

  • KMID: 2175322
  • J Korean Cancer Assoc.
  • 1998 Dec;30(6):1269-1278.
PURPOSE: International Prognostic Index Model (IPIM) in aggressive non-Hodgkin's lymphoma was published and accepted generally as a better predictive model for prognosis. This study was undertaken to identify prognostic factors...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Prognostic Value of SUVmax Measured by Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography with Computed Tomography in Patients with Gallbladder Cancer

Hwang JP, Lim I, Na II, Cho EH, Kim BI, Choi CW, Lim SM

  • KMID: 2313179
  • Nucl Med Mol Imaging.
  • 2014 Jun;48(2):114-120.
OBJECTIVE: The aim of this study is to investigate the prognostic value of F-18 fluorodeoxyglucose (F-18 FDG) positron emission tomography (PET)/computed tomography (CT) in gallbladder cancer patients. METHODS: From June 2004...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Pilot Study of Bortezomib in Korean Patients with Relapsed or Refractory Myeloma

Lee KW, Yun T, Song EK, Na II, Shin H, Bang SM, Lee JH, Lee ST, Kim JH, Yoon SS, Lee JS, Park S, Kim BK, Kim NK

Recent clinical trials showed that bortezomib, a novel proteasome inhibitor, had therapeutic activity in multiple myeloma. However, there was no data about the feasibility of bortezomib in Korean patients. We...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr